Skip to main content
Top
Published in: AIDS and Behavior 2/2020

01-02-2020 | Care | Original Paper

Improving Monitoring of Engagement in HIV Care for Women in Option B+: A Pilot Test of Biometric Fingerprint Scanning in Lilongwe, Malawi

Authors: Angela M. Bengtson, Wiza Kumwenda, Mark Lurie, Brandon Klyn, Michael Owino, William C. Miller, Vivian Go, Mina C. Hosseinipour

Published in: AIDS and Behavior | Issue 2/2020

Login to get access

Abstract

Sustained engagement in HIV care is critical to the success of Option B+ for HIV-infected pregnant women. However, monitoring women’s engagement in care across clinics and over time is challenging due to migration and clinic transfers. Improved strategies to identify and monitor women’s engagement in HIV care across a network of clinics are needed, but have not been pilot tested. We evaluated the feasibility and acceptability of biometric fingerprint scanning to identify women and monitor HIV visit attendance among women in Option B+. Over a 3-month period, we enrolled HIV-infected pregnant women receiving care at two antenatal clinics in Lilongwe, Malawi and monitored their engagement in care using biometric fingerprint scanning and the standard-of-care electronic medical record (EMR) monitoring system. Biometric data was collected by trained research assistants, who uploaded and synced data across study sites daily using wireless internet. We collected data weekly on the biometric scanner performance, reliability, and usability. We assessed the feasibility and acceptability of using biometric fingerprint scanning to record HIV visits during exit interviews with a sample of participants and healthcare workers and by comparing visit concordance between the biometric fingerprint scanning and EMR systems. We enrolled 314 HIV-infected pregnant women and 51 HCWs (n = 365 total participants). The majority of participants felt the biometric fingerprint scanning system was easy to use (64%), required no additional assistance (69%) and met their expectations (76%). No major issues with data security, privacy, or scanner functionality were reported by HIV-infected women or healthcare workers. Of the 542 HIV visits captured during the study period among women in Option B+, 80% were recorded in the biometric fingerprint system versus 51% in the EMR system (PR 1.57, 95% CI 1.43, 1.72, p-value < 0.05). Among HIV-infected pregnant women engaged in HIV care, biometric fingerprint scanning is a feasible and acceptable way to monitor HIV visits and may improve the ability to monitor women’s engagement in HIV care over time and across clinics. Biometric fingerprint scanning should be scaled-up and evaluated as an implementation strategy to support sustained engagement in HIV care for women during the perinatal period.
Appendix
Available only for authorised users
Literature
2.
go back to reference Schouten EJ, Jahn A, Midiani D, Makombe SD, Mnthambala A, Chirwa Z, et al. Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet. 2011;378(9787):282–4.CrossRef Schouten EJ, Jahn A, Midiani D, Makombe SD, Mnthambala A, Chirwa Z, et al. Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet. 2011;378(9787):282–4.CrossRef
4.
go back to reference Rollins NC, Essajee SM, Bellare N, Doherty M, Hirnschall GO. Improving retention in care among pregnant women and mothers living with HIV: lessons from INSPIRE and implications for future WHO guidance and monitoring. J Acquir Immune Defic Syndr. 2017;75(Suppl 2):S111–4.CrossRef Rollins NC, Essajee SM, Bellare N, Doherty M, Hirnschall GO. Improving retention in care among pregnant women and mothers living with HIV: lessons from INSPIRE and implications for future WHO guidance and monitoring. J Acquir Immune Defic Syndr. 2017;75(Suppl 2):S111–4.CrossRef
6.
go back to reference Tippett Barr BA, van Lettow M, van Oosterhout JJ, Landes M, Shiraishi RW, Amene E, et al. National estimates and risk factors associated with early mother-to-child transmission of HIV after implementation of option B+: a cross-sectional analysis. Lancet HIV. 2018;5(12):e688–95.CrossRef Tippett Barr BA, van Lettow M, van Oosterhout JJ, Landes M, Shiraishi RW, Amene E, et al. National estimates and risk factors associated with early mother-to-child transmission of HIV after implementation of option B+: a cross-sectional analysis. Lancet HIV. 2018;5(12):e688–95.CrossRef
7.
go back to reference Knettel BA, Cichowitz C, Ngocho JS, Knippler ET, Chumba LN, Mmbaga BT, et al. Retention in HIV care during pregnancy and the postpartum period in the option B+ era: systematic review and meta-analysis of studies in Africa. J Acquir Immune Defic Syndr. 2018;77(5):427–38.CrossRef Knettel BA, Cichowitz C, Ngocho JS, Knippler ET, Chumba LN, Mmbaga BT, et al. Retention in HIV care during pregnancy and the postpartum period in the option B+ era: systematic review and meta-analysis of studies in Africa. J Acquir Immune Defic Syndr. 2018;77(5):427–38.CrossRef
8.
go back to reference Haas AD, Tenthani L, Msukwa MT, Tal K, Jahn A, Gadabu OJ, et al. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi’s option B+ programme: an observational cohort study. Lancet HIV. 2016;3(4):e175–82.CrossRef Haas AD, Tenthani L, Msukwa MT, Tal K, Jahn A, Gadabu OJ, et al. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi’s option B+ programme: an observational cohort study. Lancet HIV. 2016;3(4):e175–82.CrossRef
9.
go back to reference Tenthani L, Haas AD, Tweya H, Jahn A, van Oosterhout JJ, Chimbwandira F, et al. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (‘Option B+’) in Malawi. Aids. 2014;28(4):589–98.CrossRef Tenthani L, Haas AD, Tweya H, Jahn A, van Oosterhout JJ, Chimbwandira F, et al. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (‘Option B+’) in Malawi. Aids. 2014;28(4):589–98.CrossRef
10.
go back to reference Rice B, Boulle A, Baral S, Egger M, Mee P, Fearon E, et al. Strengthening Routine Data Systems To Track the HIV epidemic and guide the response in sub-Saharan Africa. JMIR Public Health Surveill. 2018;4(2):e36.CrossRef Rice B, Boulle A, Baral S, Egger M, Mee P, Fearon E, et al. Strengthening Routine Data Systems To Track the HIV epidemic and guide the response in sub-Saharan Africa. JMIR Public Health Surveill. 2018;4(2):e36.CrossRef
12.
go back to reference Tweya H, Gugsa S, Hosseinipour M, Speight C, Ng’ambi W, Bokosi M, et al. Understanding factors, outcomes and reasons for loss to follow-up among women in Option B+ PMTCT programme in Lilongwe, Malawi. Trop Med Int Health. 2014;19(11):1360–6.CrossRef Tweya H, Gugsa S, Hosseinipour M, Speight C, Ng’ambi W, Bokosi M, et al. Understanding factors, outcomes and reasons for loss to follow-up among women in Option B+ PMTCT programme in Lilongwe, Malawi. Trop Med Int Health. 2014;19(11):1360–6.CrossRef
13.
go back to reference Haas AD, Zaniewski E, Anderegg N, Ford N, Fox MP, Vinikoor M, et al. Retention and mortality on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV treatment programmes. J Int AIDS Soc. 2018;21(2):e25084.CrossRef Haas AD, Zaniewski E, Anderegg N, Ford N, Fox MP, Vinikoor M, et al. Retention and mortality on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV treatment programmes. J Int AIDS Soc. 2018;21(2):e25084.CrossRef
14.
go back to reference Zurcher K, Mooser A, Anderegg N, Tymejczyk O, Couvillon MJ, Nash D, et al. Outcomes of HIV-positive patients lost to follow-up in African treatment programmes. Trop Med Int Health. 2017;22(4):375–87.CrossRef Zurcher K, Mooser A, Anderegg N, Tymejczyk O, Couvillon MJ, Nash D, et al. Outcomes of HIV-positive patients lost to follow-up in African treatment programmes. Trop Med Int Health. 2017;22(4):375–87.CrossRef
15.
go back to reference World Health Organization. Consolidated guidelines on person-centred HIV patient monitoring and case surveillance. Geneva: World Health Organization; 2017. World Health Organization. Consolidated guidelines on person-centred HIV patient monitoring and case surveillance. Geneva: World Health Organization; 2017.
16.
go back to reference Wall KM, Kilembe W, Inambao M, Chen YN, McHoongo M, Kimaru L, et al. Implementation of an electronic fingerprint-linked data collection system: a feasibility and acceptability study among Zambian female sex workers. Glob Health. 2015;11(1):27.CrossRef Wall KM, Kilembe W, Inambao M, Chen YN, McHoongo M, Kimaru L, et al. Implementation of an electronic fingerprint-linked data collection system: a feasibility and acceptability study among Zambian female sex workers. Glob Health. 2015;11(1):27.CrossRef
17.
go back to reference Odei-Lartey EO, Boateng D, Danso S, Kwarteng A, Abokyi L, Amenga-Etego S, et al. The application of a biometric identification technique for linking community and hospital data in rural Ghana. Global Health Action. 2016;9:29854.CrossRef Odei-Lartey EO, Boateng D, Danso S, Kwarteng A, Abokyi L, Amenga-Etego S, et al. The application of a biometric identification technique for linking community and hospital data in rural Ghana. Global Health Action. 2016;9:29854.CrossRef
18.
go back to reference Group TSS. Using a fingerprint recognition system in a vaccine trial to avoid misclassification. Bull World Health Organ. 2007;85(1):64–7.CrossRef Group TSS. Using a fingerprint recognition system in a vaccine trial to avoid misclassification. Bull World Health Organ. 2007;85(1):64–7.CrossRef
19.
go back to reference Serwaa-Bonsu A, Herbst AJ, Reniers G, Ijaa W, Clark B, Kabudula C, et al. First experiences in the implementation of biometric technology to link data from Health and Demographic Surveillance Systems with health facility data. Glob Health Action. 2010;3:2120.CrossRef Serwaa-Bonsu A, Herbst AJ, Reniers G, Ijaa W, Clark B, Kabudula C, et al. First experiences in the implementation of biometric technology to link data from Health and Demographic Surveillance Systems with health facility data. Glob Health Action. 2010;3:2120.CrossRef
20.
go back to reference Malawi Ministroy of Health. Malawi guidelines for clinical management of HIV in children and adults. Lilongwe; 2016. Malawi Ministroy of Health. Malawi guidelines for clinical management of HIV in children and adults. Lilongwe; 2016.
21.
go back to reference Chagomerana MB, Miller WC, Tang JH, Hoffman IF, Harrington BJ, DiPrete B, et al. Prevalence of antiretroviral therapy treatment failure among HIV-infected pregnant women at first antenatal care: PMTCT Option B+ in Malawi. PLoS ONE. 2018;13(12):e0209052.CrossRef Chagomerana MB, Miller WC, Tang JH, Hoffman IF, Harrington BJ, DiPrete B, et al. Prevalence of antiretroviral therapy treatment failure among HIV-infected pregnant women at first antenatal care: PMTCT Option B+ in Malawi. PLoS ONE. 2018;13(12):e0209052.CrossRef
22.
go back to reference van Lettow M, Bedell R, Mayuni I, Mateyu G, Landes M, Chan AK, et al. Towards elimination of mother-to-child transmission of HIV: performance of different models of care for initiating lifelong antiretroviral therapy for pregnant women in Malawi (Option B+). J Int AIDS Soc. 2014;17:18994.CrossRef van Lettow M, Bedell R, Mayuni I, Mateyu G, Landes M, Chan AK, et al. Towards elimination of mother-to-child transmission of HIV: performance of different models of care for initiating lifelong antiretroviral therapy for pregnant women in Malawi (Option B+). J Int AIDS Soc. 2014;17:18994.CrossRef
23.
go back to reference Tweya H, Oboho IK, Gugsa ST, Phiri S, Rambiki E, Banda R, et al. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi. PLoS ONE. 2018;13(1):e0188488.CrossRef Tweya H, Oboho IK, Gugsa ST, Phiri S, Rambiki E, Banda R, et al. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi. PLoS ONE. 2018;13(1):e0188488.CrossRef
24.
go back to reference Storisteanu DM, Norman TL, Grigore A, Norman TL. Biometric fingerprint system to enable rapid and accurate identification of beneficiaries. Global Health Sci Pract. 2015;3(1):135–7.CrossRef Storisteanu DM, Norman TL, Grigore A, Norman TL. Biometric fingerprint system to enable rapid and accurate identification of beneficiaries. Global Health Sci Pract. 2015;3(1):135–7.CrossRef
25.
go back to reference Clouse K, Vermund SH, Maskew M, Lurie MN, MacLeod W, Malete G, et al. Mobility and clinic switching among postpartum women considered lost to HIV care in South Africa. J Acquir Immune Defic Syndr. 2017;74(4):383–9.CrossRef Clouse K, Vermund SH, Maskew M, Lurie MN, MacLeod W, Malete G, et al. Mobility and clinic switching among postpartum women considered lost to HIV care in South Africa. J Acquir Immune Defic Syndr. 2017;74(4):383–9.CrossRef
Metadata
Title
Improving Monitoring of Engagement in HIV Care for Women in Option B+: A Pilot Test of Biometric Fingerprint Scanning in Lilongwe, Malawi
Authors
Angela M. Bengtson
Wiza Kumwenda
Mark Lurie
Brandon Klyn
Michael Owino
William C. Miller
Vivian Go
Mina C. Hosseinipour
Publication date
01-02-2020
Publisher
Springer US
Published in
AIDS and Behavior / Issue 2/2020
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-019-02748-6

Other articles of this Issue 2/2020

AIDS and Behavior 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine